TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
August 14, 2023 10:25 ET
|
Trxade Health, Inc.
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file...
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
July 31, 2023 08:35 ET
|
Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
July 14, 2023 16:30 ET
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
June 23, 2023 16:40 ET
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June...
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
June 21, 2023 12:36 ET
|
Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
May 15, 2023 16:15 ET
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
November 07, 2022 16:30 ET
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
October 03, 2022 09:15 ET
|
Trxade Health, Inc.
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by...
TRxADE Group Reports Record First Quarter 2021 Financial Results
April 26, 2021 16:05 ET
|
Trxade Group, Inc.
First Quarter Revenues Increased 39% to $3.1 Million TAMPA, FL, April 26, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), a health services IT company focused on digitalizing the...